Approxima

Approxima is a MedTech startup based in Milan, Italy, founded in 2020 as a spin-off from Politecnico di Milano. The company focuses on developing a minimally invasive medical device aimed at treating tricuspid valve regurgitation by reshaping the right ventricle of the heart. This innovative device is designed to be implanted through a percutaneous procedure, guided by medical imaging, and is intended for use on a beating heart. The core product is a percutaneous right ventricle remodeling system that restores tricuspid valve function and addresses right heart dilation. Approxima is currently in the preclinical feasibility phase, conducting in-vivo studies to validate the safety and efficacy of its technology. The company aims to provide a new therapeutic option for high-risk patients with limited surgical alternatives, collaborating with hospitals, cardiologists, and healthcare providers to enhance treatment outcomes. With €7.3 million secured in funding, Approxima is advancing its technology through preclinical validations and pilot clinical trials.

• Employees16
• Founded2020